We previously demonstrated that P16
Introduction
Unregulated proliferation of cancer cells is associated with signi®cant alterations in the expression and activity of the molecular cell cycle machinery. A growth regulatory pathway implicated in determining passage through the G 1 restriction point has been de®ned which is comprised of the cyclin-dependent kinase inhibitor (CKI) p16
Ink4a (p16), cyclin D, cdk4 and the product of the RBI gene, pRB (for reviews see Sherr, 1996; Sidle et al., 1996; Weinberg, 1995) . Alterations in the expression or activity of at least one member of this pathway has been documented in the majority of human cancers.
An important target of this pathway is the product of the RBI gene, pRB (Friend et al., 1986) . Many studies have now demonstrated that a functional pRB protein is critical for the growth inhibitory activity of p16 (Lukas et al., 1995a,b; Medema et al., 1995; Parry et al., 1995; Ueki et al., 1996; Yeager et al., 1995) . In the absence of pRB, expression of p16 has little apparent eect on the cell cycle pro®le of cells. Additionally, pRB itself exhibits growth regulatory properties (Huang et al., 1988; Lee et al., 1988a,b) . So, for example, when expressed in the human osteosarcoma cell line, SAOS-2, pRB elicits a potent block to proliferation and induces morphological changes (Hinds et al., 1992) . However, while some cells are very sensitive to pRB activity, a number of other pRB-de®cient cell lines appear to be refractory to the eects of this negative regulator of proliferation (for example see Muncaster et al., 1992) . One of the best characterized of these are the human cervical carcinoma cell line, C33A (Zhu et al., 1993) . While being defective for functional pRB, ectopic expression of wild type pRB in this line failed to block proliferation. In addition, expression of a dominant mutant of pRB, Dp34 (Hamel et al., 1992a,b) , which is constitutively active due to mutations in many of its phosphorylation sites, also fails to block the C33A cell cycle (Sellers et al., 1995) . These latter data suggest that, for at least some cell types, inhibition of the downstream portion of the p16-cyclin D/cdk4-pRB-E2F pathway is not sucient to elicit a cell cycle block.
Another important target of this pathway is the family of transcription factors collectively known as E2F. The E2F family currently consists of ®ve members, E2F-1 (Helin et al., 1992; Kaelin et al., 1992) , E2F-2 (Ivey-Hoyle et al., 1993; Lees et al., 1993) , E2F-3 , E2F-4 (Beijersbergen et al., 1994; Ginsberg et al., 1994; Sardet et al., 1995) and E2F-5 (Buck et al., 1995; Hijmans et al., 1995; Sardet et al., 1995) . When heterodimerized with DP1 (Bandara et al., 1994; Helin et al., 1993; Krek et al., 1993) or DP2 (Wu et al., 1995; Zhang and Chellapan, 1995) , the E2F's eciently recognize the DNA consensus sequence TTT/(C/G)(C/G)CGC (Wade et al., 1995; Yee et al., 1989) in the promoters of genes whose expression are usually regulated in a cell cycledependent manner. These genes include dihydrofolate reductase, thymidine kinase, DNA polymerase-a, thymidylate synthetase, B-myb, cdc2, cyclin A, cyclin E, c-myc and the E2F's themselves (Botz et al., 1996; DeGregori et al., 1995a DeGregori et al., , 1997 Farnham and Schimke, 1986; Hamel et al., 1992b; Hiebert et al., 1989 Hiebert et al., , 1991 Hurford et al., 1997; Karlseder et al., 1996; Shan et al., 1994; Shimizu et al., 1995; Slansky et al., 1993; Thalmeier et al., 1989; Zhu et al., 1995) . pRB and p107 also have E2F binding sites within their promoters, and it is thought that these pocket proteins may autoregulate their own expression through these sites (Gill et al., 1994; Shan et al., 1994; Zhu et al., 1995) .
Several studies have demonstrated that unscheduled expression or overexpression of some of the E2F-2 family proteins in growth arrested cells can lead to cell cycle re-entry, suggesting that restraint of E2F activity is the critical endpoint of a variety of dierent negative growth signals. In serum starved cells, E2F-1 overexpression can induce S-phase entry (Johnson et al., 1993 (Johnson et al., , 1994b Shan et al., 1994) . Deregulated E2F-1 expression can overcome TGFb or g-irradiation-induced growth arrest as well as p21
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Ink4a mediated arrest (DeGregori et al., 1995b; Schwarz et al., 1995) . E2F-1, E2F-2 and E2F-3 overcame p16-induced cell cycle arrest of Rat 1 cells which constitutively express Bcl-2 (Lukas et al., 1996) . However, E2F-4 and E2F-5 expression in the same system failed to overcome the block unless they were co-expressed with DP1. Together with the apparent restricted tissue speci®city of expression of some of the E2Fs (Dagnino et al., 1997a,b) and pRB-family proteins (Jiang et al., 1997) , these data imply a complex cell cycle regulatory pathway where the speci®c outcomes may vary in dierent tissues and at dierent points during development.
We have been studying the eects of restoration of expression of the CKI p16
Ink4a (p16) in the p16-de®cient astrocytoma cell line, U343 MG-a (U343). p16 expression in this cell line causes a G 1 cell cycle arrest associated with an alteration in expression and activity of the pRB-and E2F-family members (Dirks et al., 1997) . This growth arrest is also associated with alteration in cell phenotype. Since pRB and the E2Fs are downstream targets of the pathway regulated by p16, we wished to determine the eect of overexpression of the dominant pRB mutant, Dp34, on the proliferation of U343 cells and determine the eect of expressing the E2F-family proteins in these p16 growth arrested astrocytoma cells. We demonstrate here that the expression of Dp34 has no apparent eect on the proliferation of U343 cells and that expression of the E2F family of transcription factors in the p16-arrested cells dier in their abilities to promote cell cycle progression and cell death. Additionally, the E2F's distinctly alter the expression of speci®c cell cycle regulatory factors in these U343 astrocytoma cells.
Results

Expression of pRB in U343 cells does not alter their cell cycle
We ®rst wished to determine if expression of a dominant mutant of pRB, Dp34, would cause cell cycle arrest of U343 astrocytomas, analogous to the eect of expressing p16 in these same cells (Figure 1) . Thus, both human SAOS-2 osteosarcoma cells and U343 astrocytomas were infected with adenovirus expressing either b-galactosidase or the Dp34 pRB dominant mutant (Hamel et al., 1992a,b) . The Western blot probed with the a-HA antibody, 12CA5, demonstrates that the HA-tagged, Dp34 mutant is expressed in both SAOS-2 cells and U343 cells. The levels of expression in the U343 cells are consistently lower than are seen for SAOS-2 by Western analysis. Staining of U343 cells revealed, however, that most of the cells in the culture were expressing the Dp34 protein (data not shown). Expression of Dp34 in SAOS-2 cells resulted in the expected changes in morphology, cells becoming¯at with abundant cytoplasm, while little eect was observed for the U343 cells. The failure of pRB to arrest U343 cells was consistent with its failure to repress E2F-1 levels. As the lower panel in Figure 1 illustrates, Dp34 expression in SAOS-2 resulted in quantitative repression of E2F-1 levels. While expression of p16 in U343 cells also represses E2F-1 expression (Dirks et al., 1997) , we saw no changes in E2F-1 levels in cells infected with the Dp34-expressing virus relative to the control bgal virus. As expected, no changes in the cell cycle pro®le of these cells were seen using FACS analysis (data not shown). Thus, despite being an important down stream target of p16 activity and a potent inhibitor of SAOS-2 proliferation, ectopic expression of Dp34 in the p16-de®cient U343 astrocytoma cells has little eect on their cell cycle.
E2F factors overcome p16-dependent G 1 arrest
We next examined whether expression of the dierent E2F-family proteins could overcome the 16-dependent cell cycle block in these cells. Induction of p16 in U343 Figure 1 Expression of the pRB mutant, Dp34, in U343 or SAOS-2 cells. Exponentially growing U343 astrocytomas or SAOS-2 osteosarcomas were infected with adenoviruses expressing b-galactosidase (b-gal) or the HA-tagged, dominant pRB mutant, Dp34. Cells were harvested after 3 days and probed for the expression of Dp34 (upper panel) using the anti-HA antibody, 12CA5, or for expression of E2F-1 (lower panel). Expression of Dp34 or E2F-1 in uninfected U343 cells is indicated (C) cells in the presence of serum results in a reversible G 1 arrest by 72 h (Dirks et al., 1997) . Associated with p16 expression in these cells is a decrease in expression of endogenous E2F-1, pRB and p107, but no change in the expression of E2F-4. Figure 2 and Table 1 demonstrates that 48 h following infection of p16-arrested astrocytomas with adenovirus expressing E2F-1, E2F-2, E2F-3, or E2F-4, cells had progressed into the S and G 2 /M phases of the cell cycle. Only E2F-5 does not aect the cell cycle pro®le of these cells, although co-expression with DP1 with E2F-5 does induce cell cycle re-entry. No eect on the p16-imposed, G 1 block is evident in cells infected with the control adenovirus.
P16 expression in U343 cells results in marked cellular enlargement and cell¯attening associated with reorganization of the cytoskeleton (Dirks et al., 1997) . As Figure 3 shows, expression of the dierent E2F's signi®cantly alters this¯at cell phenotype. E2F-1, E2F-2, E2F-3 or E2F-4 decreases astrocytoma cell size whereas infection with the E2F-5 expressing virus causes cells to further increase in size and form a completely con¯uent monolayer of cells. This altered morphology is not evident when E2F-5 is co-expressed with DP1, this latter infection having little observable eect on cell morphology and being similar to the morphology of cells following infection with the control virus.
As evident in Figure 3 and suggested by the pre-G 1 peak present in the FACS analysis in Figure 2 , expression of some of the E2F's in p16-arrested U343 cells causes cell death with characteristics consistent with apoptosis. Speci®cally, E2F-1 and E2F-2 causes death of the majority of cells by 72 h post-infection. For these E2F's, cells become rounded, detach from the culture dish, acquire large intracytoplasmic vacuoles, and show cytoplasmic blebbing and loss of a distinct nucleus (data not shown). In contrast, E2F-3 expression causes little cell death despite cells entering the cell cycle. Expression of E2F-4 only weakly induces cell death, greater than 90% of the cells still being adherent 72 h after infection. As expected from the FACS analysis, expression of E2F-5 alone or in combination with expression of DP1, has no apparent eect on cell survival. Thus, these data demonstrate that while E2F-1, E2F-2, E2F-3 or E2F-4 are all able to overcome the p16-dependent cell cycle arrest, only expression of E2F-1 and E2F-2 results in potent cell death in these U343 cells.
E2F infection alters expression of other E2Fs and pRB family members
We next examined the levels of expression and subcellular localization of the ectopically expressed E2F's following infection of the p16-arrested U343 cells (Figures 4 and 5). As expected, adenoviral infection of each of the E2F's greatly increases the levels of the speci®c E2F used (Figure 4 ). Longer exposures of these same Western blots reveal, however, that expression of some of the E2F's alters the level of expression of other E2F-family members. These changes were more carefully examined by fractionating the cells into cytoplasmic and nuclear components and assaying them for E2F expression ( Figure 5 ). For example, infection with the E2F-1 expressing adenovirus results in increased levels of E2F-1 in both the nuclear and cytoplasmic compartments. On longer exposures of this same blot, however, it is evident that ectopic expression of E2F-2 and E2F-4 also induce E2F-1 expression. The induced E2F-1 protein in all these cases is nuclear. E2F-4 levels are also aected by expression of distinct E2F-family members. E2F-4 is present in the p16-arrested U343 cells exclusively in the nuclear compartment. Infection with the E2F-4-expressing adenovirus greatly increases E2F-4 levels in both the cytoplasm and the nucleus. However, while ectopic expression of E2F-2 failed to have an appreciable eect on E2F-4 expression, infection with the E2F-1 virus increases the endogenous E2F-4 almost ®ve-fold. Thus, while both E2F-1 and E2F-2 drive these p16-arrested astrocytomas into the cell cycle leading to cell death, these two E2F-family proteins distinctly aect the expression of at least one E2F-family member.
Since expression of some of the E2F-family members in the p16-growth arrested U343 cells alters the expression of a number of the endogenous E2F's, we next determined whether E2F expression in¯uences expression of other cell cycle regulatory proteins. Thus, as depicted in Figure 6 , the steady-state levels of cdk2, cyclin E, c-myc were determined by Western analysis. Cdk2 (Figure 6a ) migrates as a single species in the p16-arrested cells infected with the empty virus (CMV lane). All of the E2F-family proteins which induced cell cycle progression result in the appearance of the faster migrating, hyperphosphorylated, active form of cdk2. However, expression of two speci®c, E2F's, E2F-2 and E2F-4, also increase the overall level of cdk2 in these cells (an increase in cdk2 levels is also seen for E2F5/ DP1). The kinase activity associated with cdk2 was determined following immunoprecipitation with an acdk2 antibody ( Figure 6b ). As expected the amount of cdk2 immunoprecipitated from the cells infected with the dierent E2F's re¯ected the relative levels of cdk2 observed by Western analysis (Figure 6a ). However, only cells infected with the E2F-4-expressing virus show a signi®cant, large increase in cdk2-associated kinase activity (Figure 6b ), while cdk2-associated kinase activity in E2F-1 and E2F-2 infected cells are increased only moderately. The alterations in cdk2-associated kinase activities could be somewhat correlated with the changes in cyclin E levels in these cells, the levels of this latter cell cycle regulatory protein also being distinctly altered by the dierent E2F's ( Figure 6a ). Speci®cally, all of the E2F's which cause cell cycle progression increase cyclin E levels. However, E2F-1, E2F-2 and E2F-4 expression results in a greater than 15-fold greater increase in cyclin E levels relative to its increase seen for E2F-3 and E2F-5/ DP1. We also determined if the cell cycle progression mediated by expression of the E2F-family members might depend on c-myc induction. As Figure 6a clearly demonstrates, however, the E2F's which overcome p16-dependent cell cycle arrest, including those which induce cell death, do so independent of c-myc induction.
We next examined the expression of the pRB-family proteins following E2F-family protein expression (Figure 7 ). In the case of pRB, E2F-1 and E2F-4 induce pRB expression. Only a very weak signal for pRB is detectable following infection with the viruses expressing E2F-2, E2F-3 or E2F-5/DP1. The levels for pRB in the latter cases are identical to those observed in mock infection of these p16-arrested cells. p107 levels are only weakly altered following E2F-1, E2F-2, and E2F-3 expression, although a slightly greater increase in p107 was reproducibly observed following E2F-4 expression relative to the CMV controls. p130 exhibits the most varied eects following E2F expression. Only E2F-4 signi®cantly increases p130, the p130 in these cells found in both the hypo-and hyperphosphorylated forms. In contrast to E2F-4, expression of E2F-2 and E2F-3, both of which cause cell cycle reentry, result in repression of p130 levels while E2F-1 expression has little eect on the level or phosphorylation state of p130.
Taken together, we have demonstrated that the dierent E2F's exhibit distinct biological activities when expressed in astrocytomas growth arrested due to expression of the cyclin-dependent kinase inhibitor, p16. These activities include their ability to induce cell death and to speci®cally alter the expression of distinct cell cycle regulatory proteins.
Discussion
The E2F-family proteins are important targets of the pRB-family of transcriptional repressors. Deregulated E2F activity overcomes cell cycle arrest imposed by a variety of signals including that of CKI's (DeGregori et al., 1995b; Lukas et al., 1996) . Additionally, deregulation of E2F activity has been associated with cellular transformation (Johnson et al., 1994a; Singh et al., 1994; Xu et al., 1995 ). As we demonstrate here, the E2F's exhibit distinct activities when overcoming p16-mediated G 1 cell cycle arrest. These distinct activities include their ability to cause cell death, alter cell morphology and alter the expression of distinct cell cycle regulatory proteins.
Our data demonstrate that deregulated expression of E2F-1, E2F-2, E2F-3, or E2F-4 overcome a p16-dependent G 1 cell cycle arrest in U343 astrocytomas. E2F-5 overcomes the p16 block only when coexpressed with DP1, presumably due to the nuclear localization of E2F-5 only in the context of added DP1. These data are in contrast to a previous report in Figure 4 E2F protein expression in infected U343 cells. p16-arrested U343 cells were infected with control adenovirus (CMV) or viruses expressing E2F-1, E2F-2, E2F-3, E2F-4, E2F-5 or E2F-5 together with DP1. Whole cell lysates were prepared and the expression of each of the E2F's in each infection assessed by Western analysis using antibodies speci®c to the individual E2F-family members. As expected, infection of each of the E2F's resulted in signi®cant increases in the expression of that particular E2F. Interesting, for E2F-5, co-expression with DP1 resulted in a signi®cant change in its mobility, the majority of E2F-5 in the latter case present in the slower migrating form which forced expression of E2F-1 but not E2F-4 could overcome a p16-induced cell cycle block (Lukas et al., 1996) . In this latter case, E2F-1 or E2F-4, expressed under the control of the tetracycline operator (Gossen and Bujard, 1992) or from microinjected expression plasmids, were expressed in Rat-1 cells, programmed to express Bcl-2, or R12 cells, respectively. One apparent reason for the failure of E2F-4 to overcome the p16-dependent cell cycle block in these Rat-1 cells was its failure to eciently translocate to the nucleus following its synthesis. In the infection protocol we employed, E2F-4 was present at signi®cant levels in the cytoplasm. However, at least as much E2F-4 was present in the nuclear compartment of the infected U343 astrocytomas as in the cytoplasmic fraction. It is not evident why E2F-4 compartmentalization diers in these two cell lines. Potentially, higher levels of E2F-4 are achieved in our infection protocol, these levels being suciently dierent to cause at least some E2F-4 to translocate to the nucleus in our study. Alternatively, the strong proliferative block provided by p16 in these astrocytomas may generate a strong signal for the nuclear compartmentalization of E2F-4. The latter possibility would be consistent with the previously described, cell cycle dependent compartmentalization of this particular E2F-family member (Lindeman et al., 1997) .
Additionally, our data, using the p16-arrested U343 cells, dier signi®cantly from the results obtained using the same E2F-expressing viruses used to drive serum starved REF52 cells into cycle (DeGregori et al., 1997) . In the latter system, E2F-1, E2F-2, E2F-3 and E2F-4 all overcame the block to REF52 proliferation imposed by serum starvation. However, only E2F-1 appeared to induce apoptosis in these cells, E2F-2 having no apparent eect on cell survival in this system. Dierences in E2F regulation of a number of cell cycle regulatory proteins, speci®cally cdk2 and cyclin E, were also evident compared to the results obtained for p16-arrested U343 astrocytomas. The basis for the distinct eects of expressing the E2F's in either the p16-arrested U343 cells (this paper) and the serum starved REF52 cells (DeGregori et al., 1997) is not apparent. Indeed, with the exception of the potent induction of apoptosis by E2F-1 in most cell culture systems, the dierent E2F's appear to have somewhat distinct biological activities depending on the cell cycle status, the nature of the cell cycle block and the type of cells employed for the experiment (see Lukas et al., 1996 for example) .
All of the E2F-family members which overcame the cell cycle block imposed by p16 expression caused induction of cyclin E levels. However, three speci®c E2F's, E2F-1, E2F-2 and E2F-4, increased cyclin E levels greater than ten times higher than cyclin E induction due to E2F-3 or E2F-5/DP1 expression. We believe that the dierence in the levels of cyclin E re¯ects whether the speci®c E2F-family members directly or indirectly induce cyclin E expression. E2F's causing only modest increases in cyclin E levels would do so indirectly as a consequence of driving cells through the cell cycle. In contrast, E2F's which strongly induce cyclin E expression are predicted to directly activate cyclin E promoter activity.
Unlike the eect on cyclin E expression, E2F-induced cell cycle progression had no observable eect on c-myc expression. The c-myc promoter has been shown to be a potential target of pRB-mediated repression (Hamel et al., 1992b; Hiebert et al., 1989) . This repression was dependent on the presence of an intact E2F-binding site in the P2 promoter region. Our data and those published previously (DeGregori et al., 1995a,b) support the notion that c-myc induction does not depend on E2F transcriptional activity. Rather, these data suggest that the role of E2F in controlling cmyc expression may be to repress c-myc expression as cells exit the cell cycle. During cell cycle re-entry, c-myc induction is independent of E2F activity and would be mediated through other elements in the c-myc P2 promoter region.
While the E2F's did not aect the expression of c-myc, expression of some E2F-family members altered the levels of other cell cycle regulatory factors, including the E2F's themselves. For example, E2F-1, but not E2F-2, speci®cally increased levels of E2F-4. In a reciprocal manner, E2F-4, as well as E2F-2, induced the expression of E2F-1. The pRB-family proteins were also dierentially aected by ectopic E2F expression. Both E2F-1 and E2F-4 signi®cantly increased pRB Kinase activity (upper panel) associated with cdk2 in cells infected with control (CMV) or E2F-expressing viruses using histone HI as a substrate. Cdk2-associated kinase activity was also determined for U343 cells where p16, under the control of the tetO was repressed (o) and in cells where p16 was induced (on). The amount of cdk2 isolated for kinase assay was determined by Western analysis of a fraction of the immunoprecipitated material (lower panel). Longer exposures of this blot show low levels of cdk2 present in the CMV, E2F-1 and E2F-3 lanes (data not shown). The levels of cdk2 isolated by immunoprecipitation re¯ect their relative levels determined by Western analysis (see Figure 6a) levels. In contrast, E2F-4 speci®cally increased p130 expression while E2F-2 and E2F-3 repressed the levels of p130 (data not shown). Since all of these E2F's are capable of driving cells into the cell cycle, we conclude that each of these E2F-family proteins are involved in the transcriptional regulation of distinct targets. We predict, then, that the recognition of E2F-binding sites by the dierent E2F-family proteins will depend on the context of that binding site in a particular promoter region. Recent data have also demonstrated that the dierent pRB-family proteins participate in the regulation of distinct E2F-responsive genes (Hurford et al., 1997) . Taken together with their developmentally regulated patterns of expression (Dagnino et al., 1997a,b; Jiang et al., 1997) , these experiments predict that the distinct members of the pRB-and E2F-families may not necessarily be redundant and have, in fact, tissue-speci®c roles and/or cell cycle-speci®c activities.
It was somewhat surprising that ectopic expression of the dominant pRB mutant, Dp34 (Hamel et al., 1992a,b) , had no observable consequences on the proliferative potential of these cells. Our previous data demonstrated that p16 expression had profound eects on the phosphorylation state of pRB and the levels of pRB and E2F-1 expression (Dirks et al., 1997) . We hypothesize, therefore, that while pRB and E2F-1 are important downstream targets of p16 activity, there may exist additional downstream targets in pathways parallel to pRB-E2F-1 which are also regulated by p16. Inhibition of both (all) these pathways is required for cell cycle arrest. The existence of these pathways is supported by the recent observations that a number of cellular factors outside of the p16-cyclin D/cdk4-pRB-E2F-1 pathway can bind to speci®c members of this pathway. So, for example, the estrogen receptor has recently been shown to bind to cyclin D1 in a cdk4-independent manner (Neuman et al., 1997; Zwijsen et al., 1996 Zwijsen et al., , 1997 . Additional cyclin D1-associated factors have also been described (Hirai and Sherr, 1996) . Given the dierences in susceptibly of dierent cell lines to the eects of pRB expression, we expect that some of these pathways may be tissue or cell speci®c.
Materials and methods
Cell culture
The malignant astrocytoma cell line U343MG-a (U343), reconstituted with p16
Ink4a (p16) under the control of the tetracycline repressor system (Gossen and Bujard, 1992), has been described elsewhere (Dirks et al., 1997) . For p16 induction, 1 ± 2610 5 cells were plated in 6 cm dishes. The following day, medium containing 10% serum and 4 mg/ mL tetracycline (p16 repressed) was replaced with medium containing 10% serum without tetracycline (p16 induced).
Infection of cells with adenoviruses
U343 astrocytoma cells were growth arrested following induction of p16 for 5 days as previously described (Dirks et al., 1997) . Cells were then infected with adenovirus expressing either E2F-1, E2F-2, E2F-3, E2F-4 or E2F-5, under the control of the cytomegaloviral (CMV) promoter (viruses a kind gift of J DeGregori, G Leone and J Nevins (DeGregori et al., 1997) ). An adenovirus containing only the CMV promoter was used as a control and, in the case of E2F-5, co-infection with a virus expressing the E2F heterodimeric partner, DP1, was also performed. Cells were infected with 100 p.f.u./cell and were maintained in 10% serum containing medium without tetracycline (p16 induced). Adenoviruses expressing either bgalactosidase or the HA-tagged, pRB mutant, Dp34, were kindly provided by J Leiden and have been described previously (Wang et al., 1993) . Human osteosarcoma SAOS-2 cells or U343 cells were infected with these two viruses as described for the adenoviruses expressing the E2F's with the exception that a multiplicity of infection of ten was used. Expression of the Dp34-HA mutant was determined by Western analysis using the anti-HA antibody 12CA5 as we have previously described (Hamel et al., 1992a,b) .
Flow cytometric analysis
Determination of the proportion of cells present at dierent stages of the cell cycle was performed by FACS analysis as we have described previously (Kiess et al., 1995a) . The percentage of cells in dierent phases of the 
Antibodies
Antibodies to cdk2 (SC-163), cdk4 (SC-260), cyclin E (SC-198), p107 (SC-318), p130 (SC-317), E2F-1 (SC-193), E2F2 (SC-633), E2F3 (SC-878), E2F-4 (SC-866x) and E2F-5 (SC-999) were obtained from Santa Cruz Biotech. Inc. (Santa Cruz, CA) and to pRB (14001A) and p16 (15126E) from Pharmingen (Richmond, CA). The monoclonal antibody to c-myc was provided by Dr L Penn (The Ontario Cancer Institute, Toronto, ON).
Western blots and kinase assays
Total cell lysates (120 mM NaCl, 0.5% NP-40, 50 mM TrisCl pH 8.0, 10 ± 30 mg) or fractionated nuclear and cytoplasmic lysates were made as previously described (Kiess et al., 1995a) and were subjected to SDS ± PAGE. Proteins were transferred to polyvinylidene di¯uoride (Immobilon P) membranes by semi-dry transfer. Blots were rehydrated prior to immunodetection, and then were blocked in 5% skim milk in PBS/0.1% Tween 20 at room temperature for 1 h. Primary and secondary antibody incubations were performed in blocking solution at room temperature for 1 h. Primary antibodies were diluted 1 : 1000 and the goat anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antibodies were used at 1 : 5000 ± 1 : 8000 dilutions. Detection was performed using the enhanced chemiluminescence system (ECL, Amersham, Oakville, ON) according to the manufacturer's instructions. For kinase assay, cdk2 was immunoprecipitated from 200 mg U343 cell lysate using the a-cdk2 antibody (SC-163) as we have performed previously (Kiess et al., 1995b and references therein) . A portion of this immunoprecipitate was used to determine by Western analysis the amount of cdk2 isolated. The remainder was used in kinase assays with Histone HI as substrate, as we have described previously (Kiess et al., 1995b) .
